Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tracie Saunders

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 24, 2017
First-in-Human Clinical Trial of Oral ONC201 in Patients with Refractory Solid TumorsMark N Stein, Joseph R Bertino, Howard L Kaufman, et al.
Journal for Immunotherapy of Cancer|May 24, 2019
Safety and enhanced immunostimulatory activity of the DRD2 antagonist ONC201 in advanced solid tumor patients with weekly oral administrationMark N Stein, Jyoti Malhotra, Rohinton S Tarapore, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 24, 2017
First-in-Human Clinical Trial of Oral ONC201 in Patients with Refractory Solid TumorsMark N Stein, Joseph R Bertino, Howard L Kaufman, et al.
Journal for Immunotherapy of Cancer|May 24, 2019
Safety and enhanced immunostimulatory activity of the DRD2 antagonist ONC201 in advanced solid tumor patients with weekly oral administrationMark N Stein, Jyoti Malhotra, Rohinton S Tarapore, et al.
Pageof 2